Key points are not available for this paper at this time.
Recent studies suggest that cardiac amyloidosis (CA) is significantly underdiagnosed. For rare diseases like CA, the optimal selection of cases and controls for artificial intelligence model training is unknown and can significantly impact model performance.
Vrudhula et al. (Thu,) studied this question.